Study guide
7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
IJCAHPO Certified Retina Technician CRT
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview: Current CRT Requirements & Blueprint
Exam Overview: Current Requirements, Scope & Study Plan
2 Chapter 1: History Taking, Triage & Clinical Documentation
1.1 Comprehensive Ophthalmic & Medical History for Retina Patients 1.2 Telephone Triage, Urgent Symptoms & Emergency Scheduling 1.3 Scribing, Electronic Health Records & Retinal Billing Codes
3 Chapter 2: Visual Assessment & Low Vision Rehabilitation
2.1 Standardized Visual Acuity Testing & Optotypes 2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP 2.3 Low Vision Definitions, Optical Devices & Patient Counseling
4 Chapter 3: Pupil Assessment & Visual Field Testing
3.1 Pupillary Examination & Relative Afferent Pupillary Defect 3.2 Confrontation Fields & Automated Perimetry in Retina 3.3 Amsler Grid Testing & Metamorphopsia Monitoring
5 Chapter 4: Tonometry & Ocular Motility
4.1 Goldmann Applanation & Handheld Tonometry Techniques 4.2 Tonometer Disinfection, Calibration & Post-Procedure IOP Monitoring 4.3 Ocular Motility Assessment, Strabismus & Alignment Testing
6 Chapter 5: Diagnostic Ophthalmic Ultrasound
5.1 Ophthalmic B-Scan Echography for Posterior Segment Pathology 5.2 Standardized A-Scan Echography & Optical Biometry
7 Chapter 6: Slit Lamp, Electrophysiology & Supplemental Testing
6.1 Slit Lamp Biomicroscopy, Illumination & Fundus Lenses 6.2 Color Vision Assessment & Hertel Exophthalmometry 6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG
8 Chapter 7: Ophthalmic Microbiology & Infection Control
7.1 Ocular Pathogens & Routes of Disease Transmission 7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
9 Chapter 8: General Retinal Pharmacology & Therapeutics
8.1 Ocular Drug Delivery Methods & Routes of Administration 8.2 Mydriatics, Cycloplegics & Diagnostic Ophthalmic Dyes 8.3 Anesthetics, Glaucoma Agents & Prescription Verification
10 Chapter 9: Anti-VEGF Therapies, Steroids & Retinal Toxicity
9.1 Anti-VEGF Agents & Neovascular Retinal Diseases 9.2 Corticosteroids, Sustained-Release Implants & AREDS Supplements 9.3 Systemic Medication Retinal Toxicity & Plaquenil Screening
11 Chapter 10: Surgical Assisting & Intravitreal Procedures
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks 10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols 10.3 Surgical Instrument Handling, Tray Setup & Sterilization
12 Chapter 11: Patient Services, Education & Clinical Care
11.1 Patient Education, Chronic Disease Counseling & Treatment Adherence 11.2 Special Needs Accommodations, Patient Diversity & Interpersonal Skills 11.3 Ophthalmic Emergencies, First Aid & Clinical Care Coordination 11.4 Clinic Operations, Research Support, Forms & Referrals
13 Chapter 12: General Ocular Anatomy & Retinal Physiology
12.1 Ocular Anatomy, Orbit & Posterior Segment Architecture 12.2 Ten Retinal Layers, Photoreceptors & Macular Anatomy 12.3 Ocular Blood Supply, Microcirculation & Vitreoretinal Interface 12.4 Body Systems, Ocular Adnexa & Medical Terminology
14 Chapter 13: Retinal Pathology & Systemic Disease Manifestations
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions 13.2 Diabetic Retinopathy & Systemic Diseases Affecting the Retina 13.3 Peripheral Retinal Degenerations, Tears & Detachments
15 Chapter 14: Ophthalmic Optics & Lensometry
14.1 Principles of Ophthalmic Optics & Refraction 14.2 Manual & Automated Lensometry Techniques
16 Chapter 15: Fundus Photography & Ophthalmic Angiography
15.1 Fundus Photography Techniques & Fundus Autofluorescence 15.2 Fluorescein Angiography Principles, Phases & Image Interpretation 15.3 Indocyanine Green Angiography & Angiographic Complication Management
17 Chapter 16: Optical Coherence Tomography (OCT & OCT-A)
16.1 OCT Principles, Scan Acquisition & Artifact Recognition 16.2 Structural OCT Interpretation: Retinal Fluid & Biomarkers 16.3 Optical Coherence Tomography Angiography (OCT-A) Principles & Flow
18 Chapter 17: Equipment Maintenance, Ethics & Regulatory Compliance
17.1 Equipment Maintenance, Calibration Schedules & Clinic Safety 17.2 Medical Ethics, Scope of Practice & Informed Consent 17.3 Patient Privacy, HIPAA Standards & Hazardous Waste Disposal
7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
Key Takeaways Explain This Topic AI
Standard precautions apply to every patient; add transmission-based precautions and respiratory controls when the risk assessment or policy requires them.
Ocular antisepsis uses the ordered product and validated contact time; aqueous ophthalmic preparations are not interchangeable with alcohol-containing skin products.
A vitreous specimen is labeled at the bedside with patient, eye, source, date and time, then transported in the laboratory-specified containers and conditions.
Do not guess culture media, dilution, dose, or beyond-use time; reconcile the order and use pharmacy-prepared or protocol-authorized medications.
Any break in sterility, labeling mismatch, needlestick, splash, or delayed transport is stopped, reported, documented, and managed through the approved pathway.
Last updated: September 2026
Clinical Asepsis and Vitreous Specimen Collection
Intraocular procedures have little tolerance for contamination. The technician's role is to create a reliable environment, protect the sterile field, preserve specimen identity, and escalate any break. Aseptic technique does not mean that every item in the room is sterile; it means clean and sterile zones are deliberately separated and protected.
Standard precautions and preparation
Perform hand hygiene at the required moments and select personal protective equipment from the anticipated exposure. Clean and disinfect the room and reusable equipment with products compatible with each surface. Keep medication preparation away from sinks, used instruments, specimens, food, and personal items.
Before a procedure, reconcile two patient identifiers, eye and site, procedure, medication, concentration, dose, route, allergies, expiration, and consent or order status as assigned. The team resolves every mismatch before opening or administering a product.
Masks, speaking limits, sterile drapes, eyelid isolation, and other controls follow current procedure policy. Their purpose is to reduce contamination from droplets, lashes, lids, hands, and the environment. A sterile glove that touches a nonsterile surface is contaminated even if the surface looks clean.
Ocular antisepsis
Povidone-iodine is widely used for ocular-surface antisepsis before intraocular procedures. Use the ophthalmic concentration, volume, application site, and contact time specified by the current order, label, and facility protocol. Do not substitute an alcohol-containing skin preparation on the ocular surface. A reported iodine, contrast, or shellfish allergy is not automatically a povidone-iodine allergy; clarify the actual prior reaction and route it to the clinician.
If the clinician selects aqueous chlorhexidine because povidone-iodine cannot be used, follow the exact ophthalmic protocol and product concentration. Skin formulations containing alcohol or detergents can injure ocular tissue. The technician should never improvise a dilution.
Topical antibiotics are not a replacement for antisepsis. Whether they are used is determined by the procedure protocol and clinician, not by habit.
Sterile-field protection
Open packages without reaching over the field. Check integrity, indicator, expiration, lot, and moisture. Present items so the sterile operator can take them without contact. Keep hands in view and above waist level when policy defines that boundary. Limit traffic and unnecessary conversation.
If a package is torn, wet, expired, dropped, or of uncertain sterility, do not use it. If a needle, syringe tip, cap, medication port, or sterile glove contacts a nonsterile surface, announce the break immediately and replace the affected item. Concealing a break creates more harm than pausing.
Vitreous and aqueous specimens
The licensed practitioner obtains the specimen. Before collection, verify the laboratory order and obtain the required sterile containers, slides, transport media, requisitions, and labels. Different studies may require different material and handling, and local microbiology capabilities matter.
At the bedside, label the specimen with required identifiers, source such as vitreous or aqueous, right or left eye, collection date and time, and collector information. Use the laboratory's wording; do not label a specimen simply eye culture. Match every container to the requisition and use closed-loop read-back.
Small-volume ocular specimens are precious. Transport them promptly under the laboratory-specified temperature and atmosphere. Do not refrigerate, freeze, add transport medium, expel air, or transfer between containers unless the laboratory protocol requires it. If volume is limited, the clinician and laboratory determine test priority.
Medication support
Empiric intravitreal therapy can involve highly concentrated medications with very small final volumes. Dose selection, substitution, compounding, and administration are licensed-clinician and pharmacy functions. The technician may retrieve, verify, and present medications only within training and delegation. Use separate, correctly labeled syringes when the order and pharmacy instructions require them; never combine products because they look compatible.
Exposure and incident response
Dispose of sharps immediately in the approved container. Do not recap or hand-manipulate them unless an approved procedure specifically requires an engineered method. For a needlestick or mucous-membrane splash, wash or flush promptly, notify the supervisor, and enter the occupational-exposure pathway without delay. Preserve the facts, container labels, and timing.
The exam-worthy principle is simple: verify identity, preserve asepsis, follow validated instructions, protect specimen integrity, and stop whenever safety is uncertain.
Chain of custody and exposure response
Before a specimen leaves the room, match two patient identifiers, eye, source, requested tests, container, preservative, collection time, and collector information with the order. Confirm whether microbiology needs separate aerobic, anaerobic, fungal, molecular, or pathology containers; never divide a scarce ocular specimen by guesswork. Record transport temperature and time requirements and hand the sample to the approved courier or laboratory process. If labeling, container, volume, or transport is uncertain, stop and call the receiving laboratory while preserving the specimen.
For a needlestick, splash, or mucous-membrane exposure, perform immediate first aid, notify the designated supervisor, and enter the occupational-exposure pathway without waiting for symptoms. Source-patient testing and post-exposure medication require consent and professional evaluation under law and policy. Document the event factually while protecting privacy.
Checkpoint Verify If unresolved
Sterile item Package integrity, indicator, expiration, dry condition, protected field Keep out of use and replace
Medication Patient, eye, drug, concentration, dose, route, label, order Stop and reconcile with clinician or pharmacy
Specimen Patient, eye, source, container, tests, collection time Preserve specimen and call the receiving laboratory